INVOKANA is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Cardinal Health. The primary component is Canagliflozin.
Product ID | 55154-1426_35f11a41-5a34-41fa-a3cb-a35901229e08 |
NDC | 55154-1426 |
Product Type | Human Prescription Drug |
Proprietary Name | INVOKANA |
Generic Name | Canagliflozin |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 2013-03-29 |
Marketing Category | NDA / NDA |
Application Number | NDA204042 |
Labeler Name | Cardinal Health |
Substance Name | CANAGLIFLOZIN |
Active Ingredient Strength | 300 mg/1 |
Pharm Classes | Sodium-Glucose Cotransporter 2 Inhibitor [EPC],Sodium-Glucose Transporter 2 Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 2013-03-29 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA204042 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2013-03-29 |
Ingredient | Strength |
---|---|
CANAGLIFLOZIN | 300 mg/1 |
SPL SET ID: | 5f76e16f-0c24-454a-81af-4080b312c940 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
50090-4364 | INVOKANA | canagliflozin |
50090-5029 | INVOKANA | canagliflozin |
50090-5033 | INVOKANA | canagliflozin |
50090-5034 | INVOKANA | canagliflozin |
50458-140 | INVOKANA | canagliflozin |
50458-141 | INVOKANA | canagliflozin |
55154-1425 | INVOKANA | canagliflozin |
55154-1426 | INVOKANA | canagliflozin |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
INVOKANA 85592280 4369669 Live/Registered |
JOHNSON & JOHNSON 2012-04-09 |